ACHIEVED PRIMARY ENDPOINT OF STATISTICALLY SIGNIFICANT IMPROVEMENT IN MFARS COMPARED TO PLACEBO AFTER 48 WEEKS OF TREATMENT Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, announced today that the registrational Part 2 portion of the MOXIe Phase 2 trial of omaveloxolone in patients with Friedreich’s ataxia (FA) met its...
Mataró, Barcelona, Spain and Charleroi, Belgium, October 8, 2019 – Minoryx Therapeutics, a company specializing in the development of innovative treatments for orphan central nervous system (CNS) diseases, today announces that it has completed recruitment in the FRAMES phase 2 clinical trial of its novel PPARγ agonist, leriglitazone (MIN-102), in patients...
Posted on: 2019-09-24 – Posted by: Ataxia Canada – Category: publications Deadline: October 24th, 2019 Dear Members, At the next annual general assembly on November 24th 2019, we will elect five (5) members to the Board of Directors. We are seeking to solicit nominations that satisfy some of...
Hello dear reader! First, I want to apologize for the rate of publication of articles on this blog that has recently slowed down: the correction of my future publication takes me a lot of time, sorry! Also, I want to respond to a comment from a reader: I did not...
Current and emerging therapies for Friedrich’s Ataxia (FA) focus on reversing the deleterious effects of such deficiency including mitochondrial augmentation and increasing frataxin levels, providing the possibility of treatment options for this physiologically complex, multisystem disorder. In this review article, the authors discuss the current and prior in vivo and...
Dear reader! So, how is it going this week? Me, more than well: Boston lost (NHL) in the Stanley Cup final – niark, niark! I … No, but no kidding, that cumulated with the victory of the Toronto Raptors (NBA) stamped a smile on face for a few days. :...
Hi reader! So, how are you doing this week? I buried the hatchet with my Ataxia. I find it hard to imagine that anyone could have pity on me; I know how to take advantage of the little that I have. I am as happy as anyone, or more, after...